Found: 5
Select item for more details and to access through your institution.
Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guérin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer.
- Published in:
- Urologia Internationalis, 2023, v. 107, n. 1, p. 64, doi. 10.1159/000520630
- By:
- Publication type:
- Article
Intravesical Treatment with Electro-Mediated Administration of Mytomicin C as Prophylaxis for Intermediate and High-Risk Nonmuscle-Invasive Bladder Cancer: A Retrospective Multicenter Study.
- Published in:
- Urologia Internationalis, 2019, v. 103, n. 3, p. 285, doi. 10.1159/000502663
- By:
- Publication type:
- Article
PRECISION MEDICINE IN LOCALIZED BLADDER CANCER: PERSONALIZING THERAPIES TO IMPROVE OUTCOMES.
- Published in:
- Archivos Españoles de Urología, 2020, v. 73, n. 10, p. 1016
- By:
- Publication type:
- Article
Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up.
- Published in:
- Minerva Urology & Nephrology, 2022, v. 74, n. 5, p. 570, doi. 10.23736/S2724-6051.21.04436-0
- By:
- Publication type:
- Article
The Impact of Primary Tumor Location on Long-Term Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 12, p. 1363, doi. 10.3390/jpm11121363
- By:
- Publication type:
- Article